Cisplatin-induced hyponatremia

被引:0
|
作者
Peyrade, F
Taillan, B
Lebrun, C
Bendini, JC
Passerron, C
Dujardin, P
机构
[1] HOP CIMIEZ,SERV HEMATOL MED INTERNE,F-06003 NICE,FRANCE
[2] HOP LOUIS PASTEUR,GRP NEUROONCOL,F-06002 NICE,FRANCE
来源
PRESSE MEDICALE | 1997年 / 26卷 / 32期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cisplatin is one of the most widely used agents in cancer treatment. Cisplatin regimens can lead to a more or less pronounced hyponatremia in 4 to 10% of cases due to salt wasting with hypomagnesemia and normokaliemia. Functional and renal failure and orthostatic hypotension can be observed. CASE REPORT: A 54-year-old woman with brain metastases of a non-small-cell lung cancer was given a chemotherapy regimen containing cisplatin. Hyponatremia mia with confusion occurred after each cisplatin perfusion. The diagnosis retained was cisplatin-induced salt wasting. The patient was given salt prolonged supplementation and carboplatin was substituted for cisplatin in the chemotherapy regimen. DISCUSSION: Hyponatremia frequently occurs in cancer patients. Cisplatin-induced hyponatremia requires specific management Treatment is based on sodium intake which sometimes takes several months to replete stores. Carboplatin can be used instead of cisplatin in case of major hyponatremia. (C) 1997, Masson, Paris.
引用
收藏
页码:1523 / 1525
页数:3
相关论文
共 50 条
  • [21] Cisplatin-induced encephalopathy and seizures
    Steeghs, N
    de Jongh, FE
    Smitt, PAES
    van den Bent, MJ
    ANTI-CANCER DRUGS, 2003, 14 (06) : 443 - 446
  • [22] PREVENTION OF CISPLATIN-INDUCED EMESIS
    ROILA, F
    TONATO, M
    BALLATORI, E
    DELFAVERO, A
    LANCET, 1992, 340 (8825): : 972 - 972
  • [23] CISPLATIN-INDUCED GASTRIC PARESIS
    COHEN, SC
    MOLLMAN, JE
    JOURNAL OF NEURO-ONCOLOGY, 1987, 5 (03) : 237 - 240
  • [24] Cisplatin-induced hypokalemic paralysis
    Mohammadianpanah, M
    Omidvari, S
    Mosalaei, A
    Ahmadloo, N
    CLINICAL THERAPEUTICS, 2004, 26 (08) : 1320 - 1323
  • [25] Cisplatin-Induced Anorexia and Ghrelin
    Hattori, Tomohisa
    Yakabi, Koji
    Takeda, Hiroshi
    ANOREXIA, 2013, 92 : 301 - 317
  • [26] CISPLATIN-INDUCED HEPATIC TOXICITY
    POLLERA, CF
    AMEGLIO, F
    NARDI, M
    VITELLI, G
    MAROLLA, P
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) : 318 - 319
  • [27] CISPLATIN-INDUCED ANEMIA - REPLY
    GETAZ, EP
    BECKLEY, S
    FITZPATRICK, J
    DOZIER, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (02): : 110 - 111
  • [28] Cisplatin-induced activation of the EGF receptor
    Benhar, M
    Engelberg, D
    Levitzki, A
    ONCOGENE, 2002, 21 (57) : 8723 - 8731
  • [29] Cisplatin-induced delayed emesis in pigeons
    Tanihata, S
    Suzuki, M
    Ohata, S
    Uchiyama, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R435 - R435
  • [30] Cisplatin-induced cytoxicity: is the nucleus relevant?
    Sheikh-Hamad, David
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (01) : F42 - F43